An overview of ITF Pharma UK
Since 2023, Italfarmaco has been in the UK with its ITF Pharma UK subsidiary offering future-oriented medical care and tailor-made services. The UK company is focused on developing new rare disease treatments and ensuring access for patients.
Our commitment
ITF Pharma UK is committed and motivated to making a real difference in rare diseases and aims to harness the unique expertise of our dedicated UK team. Together with the experience and support of the Italfarmaco group we are well placed to provide added value to the rare disease community. Being in the UK allows us to be in the same space as other world leading companies, collectively striving to solve complex challenges. We are passionate and determined in our quest to drive life-changing innovation, ground-breaking science, and provide progressive solutions that can support patients in the long term.
The UK is supported by years of Italfarmaco’s global experience
Here’s where our expertise brings effectiveness.
Italfarmaco’s expertise in developing highly effective preparations in many therapy areas, uniquely positions us to think innovatively and tackle the sophisticated problems rare diseases present
